P3 Health Partners
PIII
21 hedge funds and large institutions have $3.48M invested in P3 Health Partners in 2026 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
157% more capital inflows, than outflows
Capital inflows: $1.28M | Capital outflows: $498K
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
24% more funds holding
Funds holding: 17 → 21 (+4)
2.3% more ownership
Funds ownership: 7.39% → 9.7% (+2.3%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$405K |
| 2 |
HRT Financial
New York
|
+$295K |
| 3 |
MA
MYDA Advisors
Woodmere,
New York
|
+$149K |
| 4 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
+$121K |
| 5 |
AWC
Abundance Wealth Counselors
State College,
Pennsylvania
|
+$119K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
-$217K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$65.5K |
| 3 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
-$55.3K |
| 4 |
Diversified Trust
Memphis,
Tennessee
|
-$51.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$41.2K |
PIII Hedge Fund Activity: Q2 2026 in Review
21 of the 8,353 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q2 2026, worth a combined $3.48M — up 364% from $750K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new PIII positions and 4 closed out — a net gain of 4 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $405K. The largest seller was Vanguard Capital Management, cutting an estimated $217K.
- 21 institutional investors held P3 Health Partners (PIII) as of Q2 2026, up from 17 in Q1 2026.
- Funds reported $3.48M of P3 Health Partners stock for Q2 2026, up 364% quarter-over-quarter.
- 8 funds opened new P3 Health Partners positions in Q2 2026 and 4 closed out, a net change of +4 holders.
- The largest P3 Health Partners buyer in Q2 2026 was Jane Street, an estimated $405K added.
- The largest P3 Health Partners seller in Q2 2026 was Vanguard Capital Management, an estimated $217K sold.
Based on aggregated 13F filings for Q2 2026.